Krystal Biotech Unites Data Processes for Collaborative Innovation
Krystal Biotech enhanced collaboration and productivity across its expanding R&D teams by implementing the Dotmatics Electronic Lab Notebook and Platform, which unified disparate data processes, streamlined data management, and enabled scientists to efficiently link and analyze experimental data for innovative gene therapy development.
Krystal Biotech Optimizes Data Processes to Drive Collaborative Innovation
Krystal Biotech is a leader in developing redosable gene therapies for rare diseases, which demands both scientific innovation and operational excellence.
Challenge: Time that could be spent in the lab was instead spent recording and tracking down data across various software programs and systems. Disparate, unstandardized data storage with broken communication caused inefficient data management and analysis.
Goal: In order for their scientists to innovate, especially as its R&D teams grew, they wanted a way to optimize their processes and maximize collaboration across teams.
Solution: Krystal Biotech implemented the Dotmatics Electronic Lab Notebook and Platform, which is currently being used across five of Krystal Biotech’s R&D groups.
Results: With the connected, robust and flexible system, productivity and cross-functional communication is better than ever. Scientists are now able to save time by more easily creating relationships between different experiments, which makes it easy to collaborate, find and extract data, and act on related experimental findings.
“With other ELNs I have used in the past, it always felt like we hit a wall. We would think, ‘This is all the ELN can do for us.’ With the Dotmatics Platform, we definitely haven’t hit a wall, and I don’t foresee that happening any time soon.”
— Chelsea Geruschat, Senior Research Associate in Downstream Process Development
Related
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.
Limitations of Existing Life Science Software—and the Opportunity to Evolve
Existing life science software tools like ELNs, LIMS, and SDMS, while essential for digitizing workflows and managing data, are limited by their siloed, non-real-time, and non-AI-integrated designs, presenting an opportunity to evolve by integrating them into unified, intelligent platforms—such as Dotmatics Luma—that enable connected, workflow-aware, multimodal scientific intelligence with adaptive workflows, real-time data flow, and cross-functional insights without replacing core systems.
Dotmatics Electronic Laboratory Notebook (ELN)
Dotmatics Electronic Laboratory Notebook (ELN) is a secure, cloud-hosted, and intuitive virtual notebook designed by scientists to streamline capturing, storing, searching, and sharing diverse scientific experiments and data types across disciplines, featuring flexible protocols, intelligent dashboards, integration with Dotmatics applications and third-party databases, and support for internal and external collaboration to enhance productivity and data-driven decision making.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Sygnature Discovery Optimizes CRO Workflows with Dotmatics ELN Platform
Sygnature Discovery enhanced its global drug discovery operations by implementing the Dotmatics ELN and Data Discovery Platform, which provided customizable workflows, centralized data management, automated lab processes, and client-facing transparency tools, resulting in improved collaboration, efficiency, and real-time project visibility.